Vertex Pharmaceuticals (VRTX)
Create an Alert
77.91
-0.89 -1.13%
NASDAQ
Jun 19, 5:00PM
BATS Real time
Currency in USD
Vertex Pharmaceuticals Shareholders Equity:
746.12M for March 31, 2013Vertex Pharmaceuticals Historical Shareholders Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 746.12M |
| Dec. 31, 2012 | 999.18M |
| Sept. 30, 2012 | 1.028B |
| June 30, 2012 | 1.038B |
| March 31, 2012 | 930.50M |
| Dec. 31, 2011 | 786.84M |
| Sept. 30, 2011 | 579.76M |
| June 30, 2011 | 307.55M |
| March 31, 2011 | 391.67M |
| Dec. 31, 2010 | 503.97M |
| Sept. 30, 2010 | 650.10M |
| June 30, 2010 | 827.14M |
| March 31, 2010 | 990.61M |
| Dec. 31, 2009 | 1.096B |
| Sept. 30, 2009 | 608.74M |
| June 30, 2009 | 729.06M |
| March 31, 2009 | 706.85M |
| Dec. 31, 2008 | 238.87M |
| Sept. 30, 2008 | 349.89M |
| June 30, 2008 | 239.92M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Shareholders' Equity
Shareholders' equity is difference between a company's total assets and total liabilities. Also referred to as stockholders' equity, net worth, or net assets.
Learn More
VRTX Shareholders Equity Benchmarks
| Companies | |
|---|---|
| Celldex Therapeutics | 194.94M |
| Regeneron Pharmaceuticals | 1.406B |
| Gilead Sciences | 10.15B |
VRTX Shareholders Equity Rankings
| Overall |
81st percentile 3051 of 16782 |
| Sector |
88th percentile 168 of 1410 in Healthcare |
| Industry |
94th percentile 25 of 454 in Biotechnology |
VRTX Shareholders Equity Range, Past 5 Years
| Minimum | 238.87M | Dec 2008 |
| Maximum | 1.096B | Dec 2009 |
| Average | 687.43M |
